Amlo Biosciences

company

About

AMLo Biosciences has identified two proteins (AMBLor™) in the skin overlying the primary tumour that are lost in high-risk melanoma.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
£2.45M
Industries
Biotechnology
Founded date
Jan 1, 2017
Number Of Employee
1 - 10
Operating Status
Active

AMLo Biosciences has identified two proteins (AMBLor™) in the skin overlying the primary tumour that are lost in high-risk melanoma.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
£2.45M
Amlo Biosciences has raised a total of £2.45M in funding over 2 rounds. Their latest funding was raised on Apr 21, 2022 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 21, 2022 Series Unknown £2.45M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Amlo Biosciences is funded by 1 investors. Ascension Life Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Ascension Life Fund Series Unknown